Articles Referencing NKTR

Zacks.com

Nektar Posts Wider Loss, Maintains View - Analyst Blog

Nektar Therapeutics ( NKTR ) reported a loss of 48 cents per share in the first quarter of 2013, wider than the year-ago loss of 34 cents and the Zacks Consensus Estimate of a loss of 41... Read >>

Zacks.com

Positive Data on Nektar's NKTR-214 - Analyst Blog

Nektar Therapeutics ( NKTR ) recently presented positive data from a preclinical study on NKTR-214. NKTR-214 targets the interleukin-2 (IL-2) receptor complex and is being developed or the... Read >>

Zacks.com

Nektar Loss Widens, Gives Guidance - Analyst Blog

Nektar Therapeutics ( NKTR ) reported a loss of 46 cents per share in the fourth quarter of 2012, wider than the year-ago loss of 33 cents and the Zacks Consensus Estimate of a loss of 45... Read >>

Zacks.com

AZN Reports Naloxegol Safety Data - Analyst Blog

AstraZeneca ( AZN ) recently announced long-term safety data from a phase III study (KODIAC-08) evaluating the use of naloxegol (25 mg once daily) in non-cancer related pain and... Read >>

Benzinga

Mid-Day Market Update: Markets Slump; Facebook Remains Up on Massive Volume

Mid-way through trading Wednesday, the Dow traded down 0.69 percent to 12,668.75 while the NASDAQ fell 0.38 percent to 2,872.87. The S&P also fell, decreasing 0.54 percent to 1,367.09. ... Read >>

NASDAQ.com News

After-Hours Earnings Report for November 13, 2012 : CSCO, IAG, WWD, HMIN, WAIR, AGRO, SVM, NKTR, GA, GFF, RENN, GOL

The following companies are expected to report earnings after hours on 11/13/2012. Visit our Earnings Calendar for a full list of expected earnings releases. Cisco Systems, Inc. ( CSCO )... Read >>

NASDAQ.com News

Pre-Market Most Active for Nov 12, 2012 : TIE, UN, BAC, GILD, MT, CLVS, FB, JEF, GRPN, DCM, NKTR, QQQ

The NASDAQ 100 Pre-Market Indicator is to 2,596.32. The total Pre-Market volume is currently 7,375,186 shares traded. The following are the most active stocks for the pre-market session :... Read >>

Kapitall

The Cancer Conference Trade: Picking Up Biotech Bargains

( List compiled by Alexander Crawford ) Biotech stocks as a whole tend to underperform after the annual American Society of Clinical Oncology (ASCO) conference in June. Many investors buy... Read >>

SeekingAlpha

Curtain Closes on ASCO: 2010's Few Winners

The Burrill Report submits: By Peter Winter In previous years, shares in biotech and pharmaceutical companies have routinely jumped on the release of positive research results at... Read >>